Last Updated: June 28, 2026

PROPARACAINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


DrugPatentWatch® Litigation and Generic Entry Outlook for Proparacaine

A generic version of PROPARACAINE was approved as proparacaine hydrochloride by BAUSCH AND LOMB on September 29th, 1995.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for PROPARACAINE?
  • What are the global sales for PROPARACAINE?
  • What is Average Wholesale Price for PROPARACAINE?
Summary for PROPARACAINE
US Patents:0
Applicants:6
NDAs:7
Drug Prices: Drug price information for PROPARACAINE
DailyMed Link:PROPARACAINE at DailyMed

US Patents and Regulatory Information for PROPARACAINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch And Lomb PROPARACAINE HYDROCHLORIDE proparacaine hydrochloride SOLUTION/DROPS;OPHTHALMIC 040074-001 Sep 29, 1995 AT RX No Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Somerset Theraps Llc PROPARACAINE HYDROCHLORIDE proparacaine hydrochloride SOLUTION/DROPS;OPHTHALMIC 215816-001 Aug 9, 2024 AT RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Rising PROPARACAINE HYDROCHLORIDE proparacaine hydrochloride SOLUTION/DROPS;OPHTHALMIC 040277-001 Mar 16, 2000 AT RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Mankind Pharma PROPARACAINE HYDROCHLORIDE proparacaine hydrochloride SOLUTION/DROPS;OPHTHALMIC 219136-001 May 21, 2025 AT RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.